CIK: 0001388551
Total reported value
$4.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | XERS | Xeris Biopharma Holdings INC | Stock-Other | 71.57% | — | — | |
| 2 | SVRA | Savara INC | Stock-Other | 8.97% | — | -89.33% | |
| 3 | RZLT | Rezolute INC | Stock-Other | 7.07% | — | — | |
| 4 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 3.39% | — | — | |
| 5 | MTEMEUR | Molecular Templates INC | Stock-Other | 2.76% | — | — | |
| 6 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 1.99% | +0.32% | — | |
| 7 | APGE | Apogee Therapeutics INC | Stock-Other | 1.11% | — | -41.04% | |
| 8 | ABVX | Abivax Sa-adr | Stock-Other | 0.97% | — | — | |
| 9 | LXEO | Lexeo Therapeutics INC | Stock-Other | 0.75% | -1.25% | — | |
| 10 | HARPUSD | Harpoon Therapeutics INC | Stock-Other | 0.70% | — | — | |
| 11 | CMPX | Compass Therapeutics INC | Stock-Other | 0.37% | -3.70% | EXIT | |
| 12 | ALLKGUSD | Allakos INC | Stock-Other | 0.36% | — | -49.91% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | XERS | Xeris Biopharma Holdings INC | +31.7% | — | Unchanged |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | +3.4% | NEW | New buy |
| 3 | BRK-B | Berkshire Hathaway Inc-cl B | +2% | NEW | New buy |
| 4 | ABVX | Abivax Sa-adr | +1% | NEW | New buy |
| 5 | LXEO | Lexeo Therapeutics INC | +0.8% | NEW | New buy |
| 6 | HARPUSD | Harpoon Therapeutics INC | +0.7% | NEW | New buy |
| 7 | RZLT | Rezolute INC | +0.5% | — | Unchanged |
| 8 | APGE | Apogee Therapeutics INC | +0.1% | -41.04% | Trim |
| 9 | ✓ | Elevation Oncology INC | -0.1% | EXIT | Sold out |
| 10 | ALLKGUSD | Allakos INC | -0.1% | -49.91% | Trim |
| 11 | CMPX | Compass Therapeutics INC | -0.3% | -49.91% | Trim |
| 12 | ACRS | Aclaris Therapeutics INC | -0.5% | EXIT | Sold out |
| 13 | MTEMEUR | Molecular Templates INC | -0.5% | — | Unchanged |
| 14 | SVRA | Savara INC | -38.6% | -89.33% | Trim |